Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02726711
PHASE1

Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic

Sponsor: Vanderbilt University

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn more about the regulation of the veins of the abdomen by the autonomic (involuntary) nervous system, and how this may affect high blood pressure. Normally, the autonomic nervous system controls how much blood flows in the veins. In people with high blood pressure, however, the autonomic nervous system is changed. This change may affect the way blood flows in the veins of the abdomen which may play a role in their high blood pressure. About 32 participants will be screened for the study. The investigators estimate 16 will be eligible to participate in all of the study days.

Official title: Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

2

Start Date

2016-04

Completion Date

2026-12

Last Updated

2026-03-13

Healthy Volunteers

No

Interventions

DRUG

Trimethaphan

Trimethaphan will be infused (0.5 - 4.0 mg IV)

DRUG

Placebo

0.5 - 4.0 mg IV to be infused

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States